Ranganatha M. Maddakkanahalli
Research Subjects
Research Interests
Ranganatha M. Maddakkanahalli has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anil Kumar Belagal Motatis
Department of Studies in Biotechnology, University of Mysore, Manasagangotri, Mysore 570006, India
1 shared publication Chandana Kumar
Department of Chemistry, Adichunchanagiri School of Natural Sciences, Adichunchanagiri University, B.G. Nagara, Mandya District, Karnataka 571448, India
1 shared publication- Komal Jaiswal
Department of Organic Chemistry, Indian Institute of Science (IISc), Bangalore, India
1 shared publication - Muddenahalli Srinivasa Sudhanva
Adichunchanagiri Institute for Molecular Medicine, Adichunchanagiri Institute of Medical Sciences, Adichunchanagiri University, B.G. Nagara, Mandya District 571448, Karnataka, India
1 shared publication Shobith Rangappa
Adichunchanagiri Institute for Molecular Medicine, Adichunchanagiri Institute of Medical Sciences, Adichunchanagiri University, B.G. Nagara, Mandya District 571448, Karnataka, India
1 shared publication- Yarabahally R. Girish
Department of Chemistry, Adichunchanagiri School of Natural Sciences, Center for Research and Innovations, Adichunchanagiri University, B.G. Nagara Mandya District, Karnataka, India, 571448
1 shared publication
Latest Publications
- 23 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (9) , 4024-4037
Engineering MoS 2 /CoSe 2 Hybrid Nanocomposites for Efficient Regeneration of Bacterially Infected Diabetic Wounds
Diabetic wounds infected with drug-resistant bacteria pose a serious global health challenge and represent a severe threat to public health. Consequently, the development of efficient and safe antibacterial agents is of great importance. In this study, MoS2/CoSe2 nanomaterials having heterojunctions were synthesized for use as a nanozyme with enhanced antibacterial activity and wound-healing applications. The MoS2/CoSe2 NC was prepared via a hydrothermal method and characterized. It displayed remarkable antibacterial action, achieving 99.71% bactericidal efficiency against Methicillin-resistant Staphylococcus aureus (MRSA). In vivo experiments in diabetic mice demonstrated that MoS2/CoSe2 significantly accelerated wound closure in MRSA-infected wounds, exhibiting excellent biocompatibility with mammalian cell lines and strong tissue-repair potential.
- 23 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (9) , 4024-4037
Engineering MoS 2 /CoSe 2 Hybrid Nanocomposites for Efficient Regeneration of Bacterially Infected Diabetic Wounds
Diabetic wounds infected with drug-resistant bacteria pose a serious global health challenge and represent a severe threat to public health. Consequently, the development of efficient and safe antibacterial agents is of great importance. In this study, MoS2/CoSe2 nanomaterials having heterojunctions were synthesized for use as a nanozyme with enhanced antibacterial activity and wound-healing applications. The MoS2/CoSe2 NC was prepared via a hydrothermal method and characterized. It displayed remarkable antibacterial action, achieving 99.71% bactericidal efficiency against Methicillin-resistant Staphylococcus aureus (MRSA). In vivo experiments in diabetic mice demonstrated that MoS2/CoSe2 significantly accelerated wound closure in MRSA-infected wounds, exhibiting excellent biocompatibility with mammalian cell lines and strong tissue-repair potential.